Executive summary 2020 will go down in history as the year when the global community was
awakened to the fragility of human health and the interdependence of the ecosystem …

Type 1 diabetes (T1D) presents a persistent medical challenge, demanding innovative
strategies for sustained glycemic control and enhanced patient well-being. Beta cells are …

Aims/hypothesis People with type 1 diabetes have reduced life expectancy (LE) compared
with the general population. Our aim is to quantify mortality changes from 2002 to 2011 in …

Cardiovascular disease (CVD) is a major cause of mortality in type 1 diabetes mellitus
(T1D). However, evidence of its risks and management is often extrapolated from studies in …

As the prevalence of type 1 and type 2 diabetes increases and population-level patterns of
alcohol and illicit drug use evolve, clinicians will continue to encounter people with diabetes …

Aims/hypothesis Tables reporting life expectancies by common risk factors are available for
individuals with type 2 diabetes; however, there is currently no published equivalent for …

Insulin represents a life-saving treatment in patients with type 1 diabetes, and technological
advancements have improved glucose control in an increasing number of patients. Despite …

Der Anteil des unbekannten Diabetes an der Gesamtprävalenz scheint in den letzten Jahren
rückläufig zu sein. von Selbstaussagen und Medikamentenangaben geschätzt [12]. Bei …

Abstract Purpose of Review In this article, we consider advanced technologies for the
management of diabetes. Recent Findings Specifically, we pose the question of which …

OBJECTIVE To describe the prevalence and clinical correlates of functional limitations in
middle-aged and older adults with long-standing type 1 diabetes. RESEARCH DESIGN …